{"id":"W2601521858","doi":"10.1002/psp4.12182","title":"Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight","year":2017,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; Eli Lilly and Company; Galderma; Astellas Pharma; Mylan; UCB Pharma; Regeneron Pharmaceuticals; Genentech; Celgene; Sanofi; Amgen; Pfizer; Meiji Seika Pharma","keywords":"Tofacitinib; Janus kinase inhibitor; Plaque psoriasis; Medicine; Psoriasis; Potency; Body weight; Internal medicine; Psoriasis Area and Severity Index; Population; Pharmacology; Body surface area; Janus kinase; Clinical trial; Dermatology; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01829861,0.0006092437,0.00251766,0.0009399645,0.000170392,0.00105603,0.0004968293,0.0006117189,0.00106527],"category_scores_gemma":[0.01378705,0.0003727843,0.005331411,0.0009291906,0.000515731,0.0008488622,0.0006456326,0.0009265225,0.0001550597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001016717,"about_ca_system_score_gemma":0.001049479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005397216,"about_ca_topic_score_gemma":0.0007176792,"domain_scores_codex":[0.9895796,0.007766665,0.0006207399,0.0005150679,0.001200829,0.0003170821],"domain_scores_gemma":[0.9835738,0.01136116,0.003621317,0.0006943104,0.0004100147,0.0003393225],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4052863,0.003259141,0.3124054,0.001145108,0.02937157,0.0002730437,0.0003342352,0.06416516,0.0316382,0.001073614,0.0006564473,0.1503917],"study_design_scores_gemma":[0.01415229,0.3096056,0.5566492,0.0001248561,0.01980102,0.000716783,0.0002218273,0.07415532,0.01804658,0.00214485,0.004237011,0.0001446254],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892292,0.004411649,0.004568381,0.0001278308,0.00002171428,0.0003268198,0.0004550553,0.00002508597,0.0008342637],"genre_scores_gemma":[0.9972204,0.0004588766,0.001547706,0.00007286515,0.00003232844,0.00008148145,0.0003605752,0.00001253677,0.0002132324],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01829861,"threshold_uncertainty_score":0.09677345,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0632394518170323,"score_gpt":0.3818505316231269,"score_spread":0.3186110798060946,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}